Intermediate-Term Outcomes After Aortic Valve Replacement With the Medtronic 3F Stentless Prosthesis.

Stefanelli, Guglielmo; Pirro, Fabrizio; Longo, Massimo; Bellisario, Alessandro; Weltert, Luca

Stefanelli, Guglielmo; Pirro, Fabrizio; Longo, Massimo; Bellisario, Alessandro; Weltert, Luca.

Affiliation

Stefanelli G; Department of Cardiac Surgery and Cardiology, Hesperia Hospital, Modena, Italy. Electronic address: guglielmostefanelli@gmail.com.
Pirro F; Department of Cardiac Surgery and Cardiology, Hesperia Hospital, Modena, Italy.
Longo M; Department of Cardiac Surgery and Cardiology, Hesperia Hospital, Modena, Italy.
Bellisario A; Department of Cardiac Surgery, European Hospital, Rome, Italy.
Weltert L; Department of Cardiac Surgery, European Hospital, Rome, Italy; Department of Biostatistics, San Camillus International University of Health Sciences, Rome, Italy.

Ann Thorac Surg ; 111(6): 1975-1982, 2021 06.

Article in En | MEDLINE | ID: mdl-33045206

Subject(s)

Aortic Valve Disease/surgery; Heart Valve Prosthesis Implantation; Heart Valve Prosthesis; Aged; Aged, 80 and over; Aortic Valve Disease/mortality; Bioprosthesis; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Prosthesis Design; Retrospective Studies; Stents; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Valve Prosthesis / Heart Valve Prosthesis Implantation / Aortic Valve Disease Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Thorac Surg Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google